<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>41 patients (30 men, 11 women, mean age 65.3 +/- 9.7 years) with probable ischemic vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> diagnosed according to stated clinical criteria at least 3 months after hospital discharge and among a few nonhospitalized subjects with thorough clinical, neurovascular and neuroimaging workup have been followed for the past 7 years with serial measures of neurological and cognitive status and cerebral blood flow using stable <z:chebi fb="3" ids="49957">xenon</z:chebi>-enhanced CT </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100543'>Cognitive impairments</z:hpo> correlated with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rather than CT measurements of infarcted brain volume </plain></SENT>
<SENT sid="2" pm="."><plain>A minimum of one follow-up was required and follow-up intervals ranged from 4 months to 6.6 years (mean 3.4 +/- 1.6 years) </plain></SENT>
<SENT sid="3" pm="."><plain>9 patients (22.0%) were lost to follow-up, 4.9% died, 9.8% became incapacitated by additional <z:hpo ids='HP_0001297'>strokes</z:hpo>, 2.4% by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and 4.9% moved away </plain></SENT>
<SENT sid="4" pm="."><plain>Cross-sequential designs adjust for problems of attrition </plain></SENT>
<SENT sid="5" pm="."><plain>Mortality rates of 1.4%/year during 1986-1993 are significantly lower than 2.0%/year between 1983 and 1986 </plain></SENT>
<SENT sid="6" pm="."><plain>Declines in mortality are attributed to control of risk factors and antiplatelet treatment of atherosclerotic cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment of patients with cardiogenic embolism </plain></SENT>
</text></document>